These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 27576282)

  • 21. Nonheparin anticoagulants for heparin-induced thrombocytopenia.
    Kelton JG; Arnold DM; Bates SM
    N Engl J Med; 2013 Feb; 368(8):737-44. PubMed ID: 23425166
    [No Abstract]   [Full Text] [Related]  

  • 22. Heparin-induced thrombocytopenia: diagnosis and management.
    Hassell K
    Thromb Res; 2008; 123 Suppl 1():S16-21. PubMed ID: 18829068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pathophysiology of heparin-induced thrombocytopenia: biological basis for treatment.
    Kelton JG
    Chest; 2005 Feb; 127(2 Suppl):9S-20S. PubMed ID: 15706026
    [No Abstract]   [Full Text] [Related]  

  • 24. Heparin-induced thrombocytopenia: treatment options and special considerations.
    Dager WE; Dougherty JA; Nguyen PH; Militello MA; Smythe MA
    Pharmacotherapy; 2007 Apr; 27(4):564-87. PubMed ID: 17381384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Heparin-induced thrombocytopenia (HIT): pathogenesis, laboratory test, and treatment].
    Matsuo T; Wanaka K; Asada R
    Rinsho Byori; 2005 Jul; 53(7):622-9. PubMed ID: 16104531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testing for heparin-induced thrombocytopenia antibodies.
    Warkentin TE; Sheppard JA
    Transfus Med Rev; 2006 Oct; 20(4):259-72. PubMed ID: 17008164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis.
    Visentin GP; Moghaddam M; Beery SE; McFarland JG; Aster RH
    J Lab Clin Med; 2001 Jul; 138(1):22-31. PubMed ID: 11433225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin-induced thrombocytopenia: a ten-year retrospective.
    Warkentin TE
    Annu Rev Med; 1999; 50():129-47. PubMed ID: 10073268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New approaches to the diagnosis of heparin-induced thrombocytopenia.
    Warkentin TE
    Chest; 2005 Feb; 127(2 Suppl):35S-45S. PubMed ID: 15706029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The laboratory diagnosis and clinical management of patients with heparin-induced thrombocytopenia: an update.
    Prechel M; Walenga JM
    Semin Thromb Hemost; 2008 Feb; 34(1):86-96. PubMed ID: 18393145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin-induced thrombocytopenia: in vitro studies on the interaction of dabigatran, rivaroxaban, and low-sulfated heparin, with platelet factor 4 and anti-PF4/heparin antibodies.
    Krauel K; Hackbarth C; Fürll B; Greinacher A
    Blood; 2012 Feb; 119(5):1248-55. PubMed ID: 22049520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
    Demma LJ; Winkler AM; Levy JH
    Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hirudin-based anticoagulant strategies for patients with suspected heparin-induced thrombocytopenia undergoing percutaneous coronary interventions and bypass grafting.
    Becker RC
    J Thromb Thrombolysis; 2000 Nov; 10 Suppl 1():59-68. PubMed ID: 11155195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin-induced thrombocytopenia.
    Warkentin TE
    Hematol Oncol Clin North Am; 2007 Aug; 21(4):589-607, v. PubMed ID: 17666280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fondaparinux thromboprophylaxis-associated heparin-induced thrombocytopenia syndrome complicated by arterial thrombotic stroke.
    Salem M; Elrefai S; Shrit MA; Warkentin TE
    Thromb Haemost; 2010 Nov; 104(5):1071-2. PubMed ID: 20806120
    [No Abstract]   [Full Text] [Related]  

  • 36. Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis.
    Greinacher A; Warkentin TE
    Expert Rev Hematol; 2008 Oct; 1(1):75-85. PubMed ID: 21083008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Heparin-induced thrombocytopenia and thrombosis. Thrombosis as an early cardinal symptom of heparin allergy].
    Folwaczny EK; Stürmer KM
    Chirurg; 2002 Dec; 73(12):1197-203. PubMed ID: 12491049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin-induced thrombocytopenia: an overview.
    Kelton JG
    Blood Rev; 2002 Mar; 16(1):77-80. PubMed ID: 11914002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up.
    Mattioli AV; Bonetti L; Zennaro M; Ambrosio G; Mattioli G
    Am Heart J; 2009 Mar; 157(3):589-95. PubMed ID: 19249435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin-induced thrombocytopenia: a review.
    Girolami B; Girolami A
    Semin Thromb Hemost; 2006 Nov; 32(8):803-9. PubMed ID: 17171593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.